Jefferies issues bullish note on buy-rated OrganiGram, upgrades Cronos and Hexo and cuts Tilray’s price target
Jefferies upgraded two Canadian cannabis stocks on Thursday and reduced his price target on a third, while remaining most bullish ...
Read more